B. Engarås

The Yield of Flexible Sigmoidoscopy and Double-Contrast Barium Enema in the Diagnosis of Neoplasms in the Large Bowel in Patients with a Positive Hemoccult Test

E. Haglind, J. Kewenter, H. Brevinge, 1995, Endoscopy.

Individual Cutoff Levels of Carcinoembryonic Antigen and CA 242 Indicate Recurrence of Colorectal Cancer With High Sensitivity

B. Engarås, 2003, Diseases of the colon and rectum.

CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.

O. Nilsson, H. Wedel, J. Kewenter, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Value of retesting subjects with a positive Hemoccult® in screening for colorectal cancer

E. Haglind, J. Kewenter, J. Jensen, 1990, The British journal of surgery.

Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60-64 years without malignant disease.

O. Nilsson, H. Wedel, J. Kewenter, 1999, The European journal of surgery = Acta chirurgica.

Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.

K. Lundholm, C. Lönnroth, A. Forslund, 2002, International journal of oncology.

Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial

E. Haglind, J. Kewenter, H. Brevinge, 1994, Diseases of the colon and rectum.

Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.

E. Haglind, J. Kewenter, H. Brevinge, 1994, Scandinavian journal of gastroenterology.

Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study

O. Nilsson, G. Hallmans, R. Palmqvist, 2003, Diseases of the colon and rectum.